Vivos Therapeutics, Inc. VVOS
Vivos Therapeutics, Inc. (Nasdaq: VVOS) is a respiratory medical device company. Its next catalyst on record is Vivos Tooth Positioners pediatric trial: Submit and publish trial results (2026).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: Vivos Tooth Positioners pediatric trial — Submit and publish trial results (2026). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| C.A.R.E. appliances (DNA, mRNA, mmRNA) | Obstructive sleep apnea, snoring | — | NA_NON_THERAPEUTIC |
| Vivos Tooth Positioners (Class I) - pediatric trial | Pediatric sleep-disordered breathing / orthodontic positioning | — | NA_NON_THERAPEUTIC |
| DNA appliance vs CPAP randomized trial with Stanford (on hold) | Moderate to severe OSA | — | NA_NON_THERAPEUTIC |
Recent results and decisions
- Oct 20, 2026n/a Nasdaq confirms Vivos Therapeutics is in compliance with minimum stockholders' equity requirement of $2.5 million following SOD transaction.
Based on the Company's Current Report on Form 8-K filed on October 19, 2026, the Staff has determined that the Company is in compliance with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1).
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other respiratory companies
- Resmed Inc RMD
- Inspire Medical Systems, Inc. INSP
- Pulmonx Corp LUNG
- QTREX Quantum Ltd. QTEX
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.